Last updated on April 18, 2014 at 13:58 EDT

Latest DOTA Stories

2014-01-10 12:25:57

DALLAS, Jan. 10, 2014 /PRNewswire/ -- Macrocyclics, Inc. (an AREVA Med company) announced today the introduction of four new products that will expand PET imaging applications with copper-64 and gallium-68 using NOTA-based chelating platforms. In addition, a new serotonin-based DOTA conjugate offers the potential to image serotoninergic neurotransmission using a radioisotope or with gadolinium by magnetic resonance imaging (MRI). (Logo:...

2013-09-18 12:31:10

GARCHING, Germany, September 18, 2013 /PRNewswire/ -- - In-licensing of superior DOTA-Tyr3-octreotide - Pharmaceutical developmentfor treatment of NETs - Excellent pharmacokinetic properties ITM Isotope Technologies Munich AG (ITM) today announced that it has entered into an exclusive licensing agreement with Progenics Pharmaceuticals Inc. for pharmaceutical development and commercialization of radiolabeled DOTA-conjugated somatostatin...